| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 |
| filingDate |
2010-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3ddff2961c54b42166998368c49ae1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd3a9ff245edc5f1c74d89e984146ba0 |
| publicationDate |
2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010106042-A |
| titleOfInvention |
Use of phosphonates for the treatment of osteoporosis |
| abstract |
The present invention provides a method for increasing bone mass of a human or other mammalian subject having osteoporosis. A high potency phosphonate compound administration method over a 30 day treatment period comprising: a) the high potency phosphonate dosing method wherein the high potency phosphonate compound is administered from 0.00001 to 0.1 mg P / kg / day. A high-efficiency phosphonate compound at the level of systemic administration to the subject, wherein the high-efficiency phosphonate compound is administered at least one day for each 30-day treatment period; and b) the 30-day treatment A method consisting of a period that may be followed by a rest period of at least one day. [Selection figure] None |
| priorityDate |
1992-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |